Patent directory · USPTO A61K / A61P
Patents matching “Dyne Therapeutics, Inc.”
49 pharma patents match "Dyne Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 49 pharmaceutical patents matching "Dyne Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12428487
Complexes comprising an anti-transferrin receptor antibody linked to an oligonicleotide and method of delivering oligonucleotide to a subject
granted -
US 12403203
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted -
US 12397062
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted -
US 12370264
Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject
granted -
US 12357703
Muscle-targeting complexes comprising an anti-transferin receptor antibody linked to an oligonucleotide and method of use thereof to induce exon skipping
granted -
US 12329824
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted -
US 12329825
Muscle targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of use thereof to induce exon skipping of exon 44 of dystrophin in a subject
granted -
US 12325753
Method of using an anti-transferrin receptor antibody to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy
granted -
US 12319743
Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject
granted -
US 12280122
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
granted -
US 12263225
Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of use thereof to target dystrophin and to treat Duchenne muscular dystrophy
granted -
US 12239717
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted -
US 12239716
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted -
US 12173079
Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide
granted -
US 12173078
Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide
granted -
US 12144868
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted -
US 12144867
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted -
US 12128109
Muscle targeting complexes and formulations for treating dystrophinopathies
granted -
US 12102687
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
granted -
US 12097263
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
granted -
US 12018087
Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject
granted -
US 12012460
Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide
granted -
US 12005124
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted -
US 11986537
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted